Valproate activates phosphodiesterase-mediated cAMP degradation: relevance to C6 glioma G1 phase progression
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 26 (1) , 73-81
- https://doi.org/10.1016/j.ntt.2003.07.013
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Automated in Vitro Screening of TeratogensToxicology and Applied Pharmacology, 2002
- PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizersMolecular Psychiatry, 2002
- Protein Kinase A Regulates Expression of p27 and Cyclin D3 to Suppress Proliferation of Leukemic T Cell LinesPublished by Elsevier ,2001
- Increase in AP-1 Transcription Factor DNA Binding Activity by Valproic AcidPublished by Springer Nature ,1997
- Effects of valproic acid on β-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cellsNeuropsychopharmacology, 1996
- G 1 Events and Regulation of Cell ProliferationScience, 1989
- The anticonvulsant sodium valproate specifically induces the expression of a rat glial heat shock protein which is identified as the collagen type IV receptorBrain Research, 1988
- VALPROIC ACID AND SPINA BIFIDAThe Lancet, 1982
- MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTSThe Lancet, 1982
- Obtaining Suspensions of Animal Cells in Metaphase from Cultures Propagated on GlassStain Technology, 1958